Sue holds a number of non executive directorships including Vectura plc, Source Bioscience plc, Cellcentric Ltd and the Rainbow Seed Fund.

She is an advisory Board member for Elara GmbH,the EIF/University of Leuven iniative in drug discovery and a Trustee of the Institute of Cancer Research.

Sue's background is in technology transfer, [1987-2000] as CEO of Cancer Research [Campaign] Technology and in venture capital [2000-2003] with Merlin Biosciences.